The biotech company reports positive results from an in vivo study of its Nuvec delivery system for an inflammatory bowel disease treatment, showcasing the platform's potential.
The healthcare company has announced a change in major shareholding, with Tracarta Limited now holding 18.02% of the voting rights.
The healthcare company has announced changes to its director shareholdings.
The pharmaceutical company has announced a change in its shareholding structure.
The healthcare company has announced a change in shareholding, with Tracarta Limited now holding an 18.02% stake.
The healthcare company has announced a change in its major shareholding structure.
The biotech company has announced the posting of a circular and notice of a general meeting to shareholders.
The biotech company is raising £1.75 million through a placing and subscription to advance its Nuvec® gene delivery platform, but the significant dilution to shareholders is a concern.
The pharmaceutical company has announced a change in major shareholding, with a key investor increasing their stake.
The biotech company will present at an investor webinar, but the announcement lacks details on business progress and financials.